Simulation circulation device for in-vitro research of aortic diseases
By designing an in vitro circulatory simulation device to simulate the human blood circulation flow and the process of aortic disease, the high cost and risk problems of studying aortic disease in the human body are solved, and the research effect of low cost and high flexibility in vitro is achieved.
Patent Information
- Application Number
- CN202411427771.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-14
- Publication Date
- 2024-11-29
AI Technical Summary
Research on aortic diseases in humans is limited by high costs, high risks and complex experimental conditions, making it difficult to effectively simulate and observe the disease process in the body.
Design an in vitro circulatory device, including a disease simulation box, ventricle cavity, venous cavity and arterial cavity, and forms a closed loop circuit through the circulation pipeline to simulate blood circulation in the human body. Components such as silicone diaphragm, solenoid valve and compressor are used to simulate ventricular contraction. and diastolic, combined with high-speed cameras and data acquisition systems, simulate the occurrence of aortic disease.
It has achieved low cost, low risk and high flexibility in vitro study of the impact of aortic disease on cardiovascular physical parameters, providing reliable test data, and can intuitively study the physical characteristics of aortic disease.
Smart Images

Figure CN119049372A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biomedical engineering, in particular to a simulated circulation device for studying aortic diseases in vitro. Background Art
[0002] Aortic disease is an extremely dangerous disease that develops rapidly, progresses rapidly, and has a very high mortality rate. Aortic disease is mainly divided into two categories: stenotic and dilatative. For example, coarctation of the aorta can be caused by congenital factors or acquired factors. Dilatative aortic disease mainly includes aortic aneurysm and aortic dissection.
[0003] When the aorta is pathologically dilated to more than 50% of the normal diameter of the blood vessel, it is called an aortic aneurysm. Generally speaking, aortic aneurysms can be divided into true aortic aneurysms and false aortic aneurysms. True aneurysms involve widening of the three layers of the blood vessel wall, while false aneurysms are formed due to partial rupture of the artery and sealing by blood clots or adjacent tissues.
[0004] Aortic dissection is an extremely fatal cardiovascular emergency characterized by a tear in the aortic intima, through which blood flows from the aortic lumen (true lumen) into the middle layer of the aortic wall (false lumen), forming varying degrees of dissection along the longitudinal axis of the aorta. The mortality rate for the first onset is about 40%. Within the first 24 hours after the onset of the disease, the mortality rate increases by 1% to 2% per hour, and the annual mortality rate can be as high as 90%. Dilated aortic disease occurs in the human body, and its development process is very rapid, so its development process is difficult to observe intuitively.
[0005] The natural blood circulation system of the human body is limited by the complex geometry, small size of terminal blood vessels and limited experimental ethics. Human research is costly and risky, and experimental conditions are subject to great safety restrictions. Human / animal experiments require ethical approval, experimental conditions are difficult to control precisely, and problems caused by interdisciplinary differences cannot be effectively avoided. Summary of the invention
[0006] In view of this, the object of the present invention is to provide a simulated circulation device for studying aortic diseases in vitro with low research cost, low risk and high flexibility of use.
[0007] The present invention is implemented by the following scheme: an in vitro simulation circulation device for studying aortic diseases, comprising a disease simulation box, a ventricular cavity, a venous cavity and an arterial cavity, wherein the disease simulation box, the ventricular cavity, the venous cavity and the arterial cavity are sequentially connected through a circulation pipeline to form a closed loop circuit for simulating the circulation flow of human blood; a first one-way valve is provided on the circulation pipeline between the disease simulation box and the ventricular cavity, which conducts one-way from the simulation box to the ventricular cavity; a second one-way valve is provided on the circulation pipeline between the ventricular cavity and the venous cavity, which conducts one-way from the ventricular cavity to the venous cavity.
[0008] Furthermore, a silicone diaphragm is provided in the ventricular cavity, and the silicone diaphragm divides the internal space of the ventricular cavity into a control chamber located above the diaphragm and a ventricle located below the diaphragm, and the ventricle is connected to the circulation pipeline; the side of the control chamber is provided with an air inlet and outlet, and the air inlet and outlet are connected to the air inlet and outlet control device.
[0009] Furthermore, the control chamber is filled with water located above the silica gel diaphragm, and an air cavity communicating with the air inlet and outlet is formed inside the control chamber above the water surface, and a liquid level gauge is provided on the top of the ventricular cavity.
[0010] Furthermore, the air inlet and outlet control device includes a two-position three-way solenoid valve, an air compressor and a vacuum pump. The air inlet and outlet are connected to either the air compressor or the vacuum pump through the two-position three-way solenoid valve. An electric proportional valve is provided on the pipeline between the air compressor and the two-position three-way solenoid valve.
[0011] Furthermore, the disease simulation box includes a box body, an aortic disease model is placed in the box body, a high-speed camera is arranged above the aortic disease model, and a screw slide module for controlling the movement of the high-speed camera is arranged above the box body.
[0012] Furthermore, a first pressure gauge is provided on the circulation pipeline between the first one-way valve and the disease simulation box, a second pressure gauge is provided on the circulation pipeline between the first one-way valve and the ventricular cavity; a flow meter and a throttle valve are provided on the circulation pipeline between the venous cavity and the arterial cavity.
[0013] Furthermore, a vent hole is provided at the top of the arterial cavity, and a valve is provided at the vent hole; and the top of the venous cavity is open.
[0014] Furthermore, the simulated blood is obtained by mixing water and glycerol in a ratio of 3:2.
[0015] Compared with the prior art, the present invention has the following beneficial effects: the simulated circulation device for in vitro aortic disease research of the present invention has low research cost, low risk, high flexibility of use, and can realize in vitro research on the effect of aortic disease on human cardiovascular physical parameters.
[0016] In order to make the objectives, technical solutions and advantages of the present invention more clearly understood, the present invention will be further described in detail below through specific embodiments and related drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1 It is a schematic diagram of the overall structure of an embodiment of the present invention; Figure 2 is a partial three-dimensional schematic diagram of a simulated blood flow circuit according to an embodiment of the present invention; Figure 3 This is a schematic diagram of the structure of a disease simulation box according to an embodiment of the present invention; Figure 4 is a schematic structural diagram of a ventricular cavity according to an embodiment of the present invention; Figure 5 This is a schematic diagram of the ventricular cavity contraction state according to an embodiment of the present invention; Figure 6 This is a schematic diagram of the diastolic state of the ventricular cavity according to an embodiment of the present invention; Figure 7 is a typical aortic pressure curve measured by an embodiment of the present invention; Figure 8 is a typical left ventricular pressure curve measured by an embodiment of the present invention; Fig. 9 It is a typical pressure-volume curve measured in the embodiment of the present invention. DETAILED DESCRIPTION
[0018] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present application. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present application belongs.
[0019] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit the exemplary embodiments according to the present application. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprise" and / or "include" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.
[0020] like Figures 1 to 9 As shown, a simulated circulation device for studying aortic diseases in vitro comprises a disease simulation box 1, a ventricular cavity 5, a venous cavity 7 and an arterial cavity 10. The top of the arterial cavity 10 is provided with an exhaust hole, and a valve is provided at the exhaust hole; the top of the venous cavity 7 is open. The disease simulation box 1, the ventricular cavity 5, the venous cavity 7 and the arterial cavity 10 are sequentially connected through a circulation pipeline to form a closed loop for simulating the circulation of human blood; the circulation pipeline between the disease simulation box 1 and the ventricular cavity 5 is provided with a first one-way valve 3 that unidirectionally conducts from the simulation box 1 to the ventricular cavity 5; the circulation pipeline between the ventricular cavity 5 and the venous cavity 7 is provided with a second one-way valve 6 that unidirectionally conducts from the ventricular cavity 5 to the venous cavity 7. The arterial cavity 10 is a closed container in which gas and liquid coexist, with simulated blood liquid at the bottom and gas at the top. The compliance of the artery is controlled by changing the gas pressure. The closed loop can simulate the pulsating flow of blood, and use sensors to collect corresponding information to provide reference test data for clinical applications. By obtaining the physical characteristics of the pulsating flow of blood, it is possible to study the impact of aortic disease on human cardiovascular physical parameters in vitro.
[0021] In this embodiment, a silicone diaphragm 504 is provided in the ventricular cavity 5, and the silicone diaphragm 504 divides the internal space of the ventricular cavity 5 into a control chamber 503 located above the diaphragm and a ventricle 505 located below the diaphragm, and the ventricle 505 is connected to the circulation pipeline; the side of the control chamber 503 is provided with an air inlet and outlet 502, and the air inlet and outlet 502 is connected to the air inlet and outlet control device.
[0022] In this embodiment, the control chamber 503 is filled with water located above the silicone diaphragm 504, and an air cavity communicating with the air inlet and outlet 502 is formed inside the control chamber 503 above the water surface, and a liquid level gauge 501 is provided on the top of the ventricular cavity 5. The liquid level gauge is used to detect the change in ventricular volume, wherein there is a certain volume of water in the control chamber, and the ventricle contains simulated blood in a closed loop. The volume change of the ventricle is detected by the liquid level gauge 501 installed above the control chamber, and the float of the liquid level gauge 501 is in the control chamber, and changes with the change of the liquid level height in the control chamber, thereby obtaining the real-time change of the ventricular volume; Figure 5 What is shown is the working principle diagram of the ventricular cavity. When the solenoid valve is opened, compressed gas is passed into the control cavity to simulate ventricular contraction. When the solenoid valve is closed, the vacuum pump quickly extracts the gas in the control cavity to simulate ventricular relaxation.
[0023] In this embodiment, the inlet and outlet air control device includes a two-position three-way solenoid valve 14, an air compressor 16 and a vacuum pump 17. The inlet and outlet 502 is connected to one of the air compressor 16 and the vacuum pump 17 through the two-position three-way solenoid valve 14, and an electric proportional valve 15 is provided on the pipeline between the air compressor 16 and the two-position three-way solenoid valve 14. The two-position three-way solenoid valve 14 is connected to the inlet and outlet, the air compressor and the vacuum pump through the air path, and the opening of the electric proportional valve controls the pressure of the compressed air. When the two-position three-way solenoid valve 14 is opened, compressed gas is introduced into the control chamber to simulate ventricular contraction; when the two-position three-way solenoid valve 14 is closed, the vacuum pump quickly extracts the gas in the control chamber to simulate ventricular diastole.
[0024] In this embodiment, the disease simulation box 1 includes a box body 101, in which an aortic disease model 102 is placed, a high-speed camera 105 is arranged above the aortic disease model 102, and a screw slide module for controlling the movement of the high-speed camera 105 is arranged above the box body. The present invention can simulate the occurrence of various aortic diseases by replacing the aortic disease model 102, and provide reference test data for clinical applications. The aortic disease model 102 is a model made of silicone based on patient-specific scanning; a typical aortic dissection disease model can be selected first to simulate the physical characteristics when aortic dissection occurs. The screw slide module includes two parallel screws 103 and a slide 104. The screw can be rotated by a motor or manually controlled by a handwheel. Threaded holes that match the screw threads are arranged at both ends of the slide 104. The screw slide module can adjust the position of the high-speed camera to facilitate focusing on the location where the model disease occurs; the high-speed camera is used to record the characteristic evolution process of the aortic disease model. In this embodiment, a first pressure gauge 2 is provided on the circulation pipeline between the first one-way valve 3 and the disease simulation box 1, a second pressure gauge 4 is provided on the circulation pipeline between the first one-way valve 3 and the ventricular cavity 5; a flow meter 9 and a throttle valve 8 are provided on the circulation pipeline between the venous cavity 7 and the arterial cavity 10.
[0025] In this embodiment, the simulated blood is obtained by mixing water and glycerol in a ratio of 3:2. The glycerol aqueous solution is used as simulated blood and has a density of 1.06 kg / m 3 The viscosity is similar to 3~4 Cst, and the solution preparation is simple.
[0026] In this embodiment, it also includes a data acquisition card 11 and a host computer 12 that are electrically connected together. The data acquisition card 11 is also electrically connected to a pressure gauge, a flow meter, a liquid level gauge, a two-position three-way solenoid valve, and an electric proportional valve. The data of the pressure gauge, the liquid level gauge, and the flow meter are transmitted to the host computer through the data acquisition card; the host computer transmits a signal to the two-position three-way solenoid valve to control the reversal of the air circuit through the data acquisition card, and transmits a signal to the electric proportional valve to control the opening and closing of the proportional valve to adjust the compressed air pressure.
[0027] The device is divided into four parts, namely the simulated blood flow circuit part, the aortic disease simulation part, the ventricular simulation part and the data acquisition and signal control part. The simulated blood flow circuit part is used to simulate the physical characteristics of actual blood pulsation flow, and the aortic disease simulation part is used to simulate the physical characteristics when aortic disease occurs. The ventricular simulation part is used to drive the simulated blood to flow in the simulated circuit. The data acquisition and signal control part controls the entire device in real time and collects and saves data.
[0028] The simulated blood flow circuit part, including the ventricular cavity, venous cavity, arterial cavity, and disease simulation box simulates the physiological characteristics of human blood circulation. The one-way valve simulates the aortic valve and mitral valve respectively, the throttle valve adjusts the size of systemic circulation resistance, and the pressure meter and flow meter collect pressure and flow signals.
[0029] The aortic disease simulation part, i.e. the disease simulation box 1, is a model made of silicone based on the patient-specific scan of the aortic disease model; the box body serves to fix the aortic disease model and the high-speed camera; the screw slide module can adjust the position of the high-speed camera to facilitate focusing on the location where the disease occurs in the model; the high-speed camera is used to record the occurrence process of the aortic disease.
[0030] The ventricle simulation part includes a ventricular cavity, a two-position three-way electromagnetic valve, an electric proportional valve, an air compressor and a vacuum pump. The ventricle simulation part uses gas as a driving force to apply positive and negative pressures to the silicone diaphragm to simulate the contraction and relaxation of the ventricle.
[0031] The data acquisition and signal control part includes a data acquisition card, a host computer, a pressure gauge, a flow meter, a liquid level gauge, a two-position three-way solenoid valve and an electric proportional valve; the data acquisition card collects voltage signals of four sensors, namely ventricular pressure, aortic pressure, system flow and ventricular volume; the electric proportional valve and the two-position three-way solenoid valve are controlled by the output signal of the data acquisition card to control the opening of the electric proportional valve and the opening and closing of the solenoid valve; the electric control part involved in the data acquisition and signal control part of the present invention belongs to the prior art, and its structure and principle are not specifically explained here.
[0032] The establishment of an in vitro simulated circulation device can conveniently and intuitively study the human vascular system, which is difficult to observe in the human body, in vitro simulation has higher flexibility. The natural blood circulation system of the human body is limited by reasons such as complex geometry, small terminal blood vessel size and experimental ethics, while the in vitro simulated circulation device is not subject to such restrictions; sensors can be installed in any location in the in vitro simulation device that is suitable for detecting response details and structurally permitted according to different research needs. The in vitro simulated circulation device can make the setting of experimental parameters easier and more accurately controlled. By controlling the relevant parameters of the in vitro simulated circulation device in vitro, the effects of different types of aortic dissection on human physiological parameters can be studied.
[0033] Taking the simulation of aortic dissection as an example, the main operation process of the device is as follows: Step 1, open the vent above the arterial cavity; Step 2: Add about 5 liters of simulated blood from the top opening of the venous cavity, wait for the simulated blood to fill the entire circuit along the pipeline, and completely discharge the gas in the circuit; Step 3, filling an appropriate amount of compressed gas from the vent hole of the arterial cavity to make the arterial cavity have appropriate compliance, and closing the vent hole of the arterial cavity; Step 4, start the running program, start the vacuum pump, air compressor and high-speed camera; Step 5, connect the gas circuit to the inlet and outlet of the ventricular cavity, and the device as a whole operates stably; Step 6, when the aortic dissection disease model ruptures, first turn off the vacuum pump, air compressor and high-speed camera, and finally stop running the program and save the collected data; Figure 7 , 8 9 are the typical aortic pressure curve, the typical left ventricular pressure curve, and the typical pressure-volume curve respectively.
[0034] Unless otherwise stated, any technical solution disclosed in the present invention disclosed above, if it discloses a numerical range, then the disclosed numerical range is a preferred numerical range, and any technician in the field should understand that the preferred numerical range is only a numerical value with a more obvious technical effect or representative value among many implementable numerical values. Since there are too many numerical values to be exhaustive, the present invention discloses some numerical values to illustrate the technical solution of the present invention, and the numerical values listed above should not constitute a limitation on the scope of protection of the present invention.
[0035] If the present invention discloses or involves components or structures that are fixedly connected to each other, then, unless otherwise stated, the fixed connection can be understood as: a detachable fixed connection (for example, connection using bolts or screws), and can also be understood as: a non-detachable fixed connection (for example, riveting, welding). Of course, the mutual fixed connection can also be replaced by an integrated structure (for example, manufactured by integrated molding using a casting process) (except when it is obviously impossible to use an integrated molding process).
[0036] In addition, unless otherwise stated, the terms used to indicate positional relationships or shapes in any of the technical solutions disclosed in the present invention include states or shapes that are approximate, similar, or close to them.
[0037] Any component provided by the present invention may be assembled from a plurality of separate components, or may be a separate component manufactured by an integral forming process.
[0038] The above is only a preferred embodiment of the present invention, and does not limit the present invention in other forms. Any technician familiar with the profession may use the above disclosed technical content to change or modify it into an equivalent embodiment with equivalent changes. However, any simple modification, equivalent change and modification made to the above embodiment according to the technical essence of the present invention without departing from the technical solution of the present invention still belongs to the protection scope of the technical solution of the present invention.
Claims
1. A simulated circulation device for studying aortic diseases in vitro, characterized in that: It includes a disease simulation box, a ventricular cavity, a venous cavity and an arterial cavity, which are connected in sequence through a circulation pipeline to form a closed loop circuit for simulating the circulation of human blood; a first one-way valve is provided on the circulation pipeline between the disease simulation box and the ventricular cavity, which conducts one-way from the simulation box to the ventricular cavity; a second one-way valve is provided on the circulation pipeline between the ventricular cavity and the venous cavity, which conducts one-way from the ventricular cavity to the venous cavity.
2. The simulated circulation device for studying aortic diseases in vitro according to claim 1, characterized in that: A silicone diaphragm is provided in the ventricular cavity, and the silicone diaphragm divides the internal space of the ventricular cavity into a control chamber located above the diaphragm and a ventricle located below the diaphragm, and the ventricle is connected to the circulation pipeline; an air inlet and outlet are provided on the side of the control chamber, and the air inlet and outlet are connected to the air inlet and outlet control device.
3. The simulated circulation device for studying aortic diseases in vitro according to claim 2, characterized in that: The control chamber is filled with water located above the silica gel diaphragm, and an air cavity communicating with the air inlet and outlet is formed inside the control chamber above the water surface, and a liquid level gauge is arranged on the top of the ventricular cavity.
4. The simulated circulation device for studying aortic diseases in vitro according to claim 2, characterized in that: The air inlet and outlet control device includes a two-position three-way solenoid valve, an air compressor and a vacuum pump. The air inlet and outlet are connected to either the air compressor or the vacuum pump through the two-position three-way solenoid valve. An electric proportional valve is provided on the pipeline between the air compressor and the two-position three-way solenoid valve.
5. The simulated circulation device for studying aortic diseases in vitro according to claim 1, characterized in that: The disease simulation box comprises a box body, an aortic disease model is placed in the box body, a high-speed camera is arranged above the aortic disease model, and a screw slide module for controlling the movement of the high-speed camera is arranged above the box body.
6. The simulated circulation device for studying aortic diseases in vitro according to claim 1, characterized in that: A first pressure gauge is provided on the circulation pipeline between the first one-way valve and the disease simulation box, a second pressure gauge is provided on the circulation pipeline between the first one-way valve and the ventricular cavity; a flow meter and a throttle valve are provided on the circulation pipeline between the venous cavity and the arterial cavity.
7. The simulated circulation device for studying aortic diseases in vitro according to claim 1, characterized in that: The top of the arterial cavity is provided with an exhaust hole, and a valve is provided at the exhaust hole; the top of the venous cavity is open.
8. The simulated circulation device for studying aortic diseases in vitro according to claim 1, characterized in that: The simulated blood is obtained by mixing water and glycerol in a ratio of 3:2.
Citation Information
Patent Citations
Simulation circulation device for in-vitro research of aortic diseases
CN223413801U
